MGTX
MeiraGTx Holdings plc
NASDAQ · Healthcare · Biotechnology · US
$13.76
−1.54%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 397.5M | 81.4M | 33.3M | 14.0M | 15.9M |
| Cost of Revenue | 11.2M | 4.8M | 23.8M | — | — |
| Gross Profit | 386.3M | 76.5M | 9.5M | 14.0M | 15.9M |
| Operating Expenses | |||||
| R&D Expense | 153.2M | 129.6M | 119.5M | 103.8M | 85.7M |
| SG&A Expense | 52.2M | 52.9M | 54.2M | 47.3M | 46.5M |
| General & Admin Expense | 52.2M | 52.9M | 54.2M | 47.3M | 46.5M |
| Selling & Marketing Expense | — | — | — | — | — |
| Other Expenses | (3.0M) | — | — | — | — |
| Total Operating Expenses | 202.3M | 182.5M | 173.7M | 151.1M | 132.3M |
| Cost and Expenses | 213.5M | 187.4M | 197.5M | 151.1M | 132.3M |
| Operating Income (EBIT) | 184.0M | (106.0M) | (164.2M) | (137.1M) | (116.4M) |
| Non-Operating | |||||
| Interest Income | 1.3M | 1.8M | 4.1M | 2.3M | 777.0K |
| Interest Expense | 12.5M | 12.2M | 13.3M | 13.2M | 4.9M |
| Net Interest Income | (11.1M) | (10.4M) | (9.1M) | (11.0M) | (4.2M) |
| Other Non-Op Income/Expense | (102.7M) | (8.2M) | 16.4M | 53.0M | (13.3M) |
| Non-Operating Income (excl Interest) | (66.2M) | (4.0M) | (29.7M) | (66.3M) | 8.3M |
| EBT (Pre-Tax Income) | 81.3M | (114.2M) | (147.8M) | (84.0M) | (129.6M) |
| Income Tax Expense | 2.4M | — | — | — | — |
| Bottom Line | |||||
| Net Income | 79.0M | (114.2M) | (147.8M) | (84.0M) | (129.6M) |
| Earnings from Cont. Ops | 78.9M | (114.2M) | (147.8M) | (84.0M) | (129.6M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 79.0M | (114.2M) | (147.8M) | (84.0M) | (129.6M) |
| Per Share | |||||
| Basic EPS | $0.76 | ($1.42) | ($2.12) | ($1.49) | ($2.87) |
| Diluted EPS | $0.71 | ($1.42) | ($2.12) | ($1.49) | ($2.87) |
| Revenue Per Share | $4.35 | $1.01 | $0.48 | $0.25 | $0.35 |
| Shares | |||||
| Basic Shares Outstanding | 91.4M | 80.4M | 69.8M | 56.5M | 45.2M |
| Diluted Shares Outstanding | 93.8M | 80.4M | 69.8M | 56.5M | 45.2M |
| Profitability Metrics | |||||
| EBITDA | 259.9M | (89.4M) | (121.7M) | (57.1M) | (116.1M) |
| D&A | 9.6M | 12.6M | 12.8M | 13.7M | 8.6M |
| EBIT | 250.2M | (102.0M) | (134.5M) | (70.8M) | (124.7M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026